How Immuno-Oncology Contributes to the Fight Against Covid-19
As the Covid-19 pandemic sweeps the world, cancer research is proving a valuable resource for…
06/07/2020 - 7 minutes
OSE Immunotherapeutics
French Partnership Deploys AI for Antibody Drug Discovery
French companies OSE Immunotherapeutics and MAbSilico are teaming up to drive the discovery of new…
13/02/2020 - 2 minutes
The Top 20 Women in Leading Biotech Roles in Europe
The biotech industry has often been criticized for its lack of gender diversity. While there…
21/05/2019 - 12 minutes
Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy
The French company OSE Immunotherapeutics has signed a partnership to use artificial intelligence to develop…
27/03/2019 - 2 minutes
Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech
OSE Immunotherapeutics could receive up to €1.1Bn from its new partner Boehringer Ingelheim, which has…
05/04/2018 - 2 minutes
Say Hello to the Top 14 Entrepreneurial Women in European Biotech
Today, March 8, is international women's day. To celebrate the achievements of women we're revisiting…
08/03/2018 - 8 minutes
Immunotherapy for Bowel Disease Gets €2.6M Milestone Payment from Bpifrance
OSE Immunotherapeutics has successfully completed the necessary milestones to bring a treatment for autoimmune disease…
22/06/2017 - 1 minute
French Biotech Enters New Agreement to Advance its IBD Immunotherapy
OSE Immunotherapeutics has teamed up with Selexis in a new license agreement to support the…
24/05/2017 - 3 minutes
Catching Up with the French Leader in Immuno-Oncology #BIOEurope
Despite the deflating attitudes towards immuno-oncology, OSE Immunotherapeutics is forging ahead. We caught up with…
07/11/2016 - 1 minute
Biotech of the Week: OSE Pharma, the ‘Significant’ Immunotherapy Player from Paris
This week, we head up full speed from Geneva with our eyes aiming towards Paris. Known…
25/03/2016 - 2 minutes
French Biotech Launches Phase III Global Trial for Lung Cancer Drug
OSE Pharma (France) has initiated the US phase III trial, Atalante 1. This global, pivotal trial will…
08/02/2016 - 2 minutes
3 French Bioentrepreneurs are Awarded for Being Stubborn
Building a company is extremely difficult and obstination is sometimes needed to reach success. The…
07/01/2016 - 3 minutes
